Melanoma News and Research

Latest Melanoma News and Research

Researchers uncover new therapeutic opportunity in the treatment of malignant melanoma

A team of researchers led by Dr Pierre Close, WELBIO researcher at the ULiège GIGA Institute and Dr Francesca Rapino has uncovered a new therapeutic opportunity in the treatment of malignant melanoma that acquired resistance to targeted therapies.

21 Jun 2018

Researchers characterize key signaling network that drives growth of triple negative breast cancers

It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy.

20 Jun 2018

Clinical trial targets metastatic colorectal cancer with new combination therapy

Rutgers Cancer Institute of New Jersey is offering a clinical trial targeting an advanced form of colorectal cancer with a combination vaccine/immunotherapy drug treatment.

19 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Scientists discover genetic causes underlying group of related infant cancers

The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators.

18 Jun 2018

Vitamin D and Diabetes: What You Need To Know

Dr. Cedric Garland discusses the results of a 12-year cohort study which showed that vitamin D3 can prevent type 1 diabetes in 80 percent of cases.

15 Jun 2018

Study finds higher response to anti-PD1 immunotherapy in older melanoma patients

With each decade of life, the likelihood of progression of melanoma after treatment with anti-PD1 immunotherapy decreased by 13 percent.

13 Jun 2018

Dermatologist gives tips to safely use stick and spray sunscreen

Sunscreen is a vital tool in the fight against skin cancer, including melanoma, the deadliest form.

13 Jun 2018

Older melanoma patients fare better on immune checkpoint blockade therapy

Patient age correlates with response to immunotherapy in melanoma and depleting regulatory T cells in young patients may have a therapeutic potential to enhance response in younger patients, according to research from The Wistar Institute. Study results were published online in Clinical Cancer Research.

13 Jun 2018

OGT increases NGS cancer panel content to provide more flexibility for customization

Oxford Gene Technology, The Molecular Genetics Company, has expanded its SureSeq myPanel™ NGS Custom Cancer Panel content - now covering 120 fully optimized cancer related genes.

From Oxford Gene Technology 13 Jun 2018

New blood test better than having a needle inserted into the eye

People diagnosed with a deadly form of cancer will no longer face the prospect of having a needle inserted into their eye thanks to a new blood test developed by Edith Cowan University researchers.

12 Jun 2018

Price check on drug ads: Would revealing costs help patients control spending?

President Donald Trump wants to control spending on drugs. One of his big ideas: include prices in advertisements, just like warnings about side effects.

6 Jun 2018

Study finds increase in lifestyle-related cancers over the past decade

Lifestyle-related cancers, such as lung, colorectal, and skin cancers, have increased globally over the past decade, according to the most comprehensive analysis of cancer-related health outcomes and patterns ever conducted.

4 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

Study: Few men undergo genetic testing despite high risk of breast cancer

Cancer is one of the leading causes of death among Americans. At least 10 percent of cancers are caused by inherited mutations in genes such as BRCA1 and BRCA2. Parents with the cancer gene mutation have a 50 percent chance of passing it on to a son or daughter.

1 Jun 2018

New minimally invasive procedure shortens hospital stay for melanoma patients

Lisa Chappell enjoys the summer sun, spending time outside and relaxing on the Coosa River at her Gadsden residence. Now, after being diagnosed with melanoma in 2015, she is much more cautious about her outdoor habits.

31 May 2018

FDA approves first stand-alone prosthetic iris in the U.S.

The U.S. Food and Drug Administration today approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part of the eye around the pupil) is completely missing or damaged due to a congenital condition called aniridia or other damage to the eye.

30 May 2018

Artificial intelligence algorithms appear to be better at detecting skin cancer

Researchers have shown for the first time that a form of artificial intelligence or machine learning known as a deep learning convolutional neural network is better than experienced dermatologists at detecting skin cancer.

29 May 2018

New AAD PSA uses social media imagery to highlight tanning hazards

As Memorial Day signals the unofficial start of summer, many teen girls will be eager to get out of school and spend time outside -; and some may want to get a tan. But a new public service advertisement from the American Academy of Dermatology encourages those who are thinking of tanning to think again.

23 May 2018

New guidelines may help pathologists to more accurately classify and diagnose invasive melanoma

In a new study, researchers have developed updated guidelines for classifying a serious form of skin cancer called invasive melanoma. The American Joint Committee on Cancer, an organization that provides information on "cancer staging," or the severity of individual cases of cancer, recently updated its guidelines for melanoma.

21 May 2018

Melanoma News and Research

Latest Melanoma News and Research

Researchers uncover new therapeutic opportunity in the treatment of malignant melanoma

Researchers characterize key signaling network that drives growth of triple negative breast cancers

Clinical trial targets metastatic colorectal cancer with new combination therapy

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Scientists discover genetic causes underlying group of related infant cancers

Vitamin D and Diabetes: What You Need To Know

Study finds higher response to anti-PD1 immunotherapy in older melanoma patients

Dermatologist gives tips to safely use stick and spray sunscreen

Older melanoma patients fare better on immune checkpoint blockade therapy

OGT increases NGS cancer panel content to provide more flexibility for customization

New blood test better than having a needle inserted into the eye

Price check on drug ads: Would revealing costs help patients control spending?

Study finds increase in lifestyle-related cancers over the past decade

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Study: Few men undergo genetic testing despite high risk of breast cancer

New minimally invasive procedure shortens hospital stay for melanoma patients

FDA approves first stand-alone prosthetic iris in the U.S.

Artificial intelligence algorithms appear to be better at detecting skin cancer

New AAD PSA uses social media imagery to highlight tanning hazards

New guidelines may help pathologists to more accurately classify and diagnose invasive melanoma

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Melanoma News and Research

Latest Melanoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in